HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of donor preservation solution and survival in lung transplantation.

AbstractBACKGROUND:
The aim of this retrospective study was to determine whether the type of preservation solution significantly alters outcomes in lung transplantation, with particular emphasis on primary graft dysfunction and mortality.
METHODS:
Data on 310 consecutive lung transplant patients, which were prospectively collected, were analyzed. The main outcome variables were all-cause mortality and primary graft dysfunction. Patients were grouped according to donor organ preservation solution, either Euro-Collins, Papworth solution or Perfadex. Multivariate analysis with an additional sensitivity analysis utilizing a propensity score for the use of Papworth solution was performed.
RESULTS:
Papworth solution was associated with significantly increased mortality compared with the other preservation solutions [odds ratio (OR) = 2.36 (1.21 to 4.58), p = 0.01]. Perfadex was associated with a reduced incidence of primary graft dysfunction at 48 hours (OR = 0.23 [0.08 to 0.68], p = 0.008). Increasing donor age was also associated with increased risk of death (OR = 1.03 [1.01 to 1.04], p = 0.004).
CONCLUSION:
Papworth solution for donor lung preservation is associated with an increased mortality in lung transplant recipients.
AuthorsSilvana F Marasco, Michael Bailey, Daniel McGlade, Greg Snell, Glen Westall, Takahiro Oto, David Pilcher
JournalThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (J Heart Lung Transplant) Vol. 30 Issue 4 Pg. 414-9 (Apr 2011) ISSN: 1557-3117 [Electronic] United States
PMID21131216 (Publication Type: Comparative Study, Journal Article)
CopyrightCrown Copyright © 2011. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Organ Preservation Solutions
Topics
  • Female
  • Humans
  • Lung Transplantation (mortality)
  • Male
  • Middle Aged
  • Organ Preservation Solutions
  • Primary Graft Dysfunction (etiology, mortality)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: